Article
Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial
2022-11-15
Abstract excerpt
<title>Abstract</title><p><bold>Background</bold>Abdominal aortic aneurysm (AAA) is a fatal disease due to the propensity to rupture. The drug treatment for small AAA without surgical indications has been controversial. Previous studies showed that high-sensitivity C-reactive protein (hs-CRP) had become a potential biomarker of the disease, and the anti-inflammatory effect of rivaroxaban for AAA has been corrobora...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5667372b-6d35-5b45-bfb4-ac1a7b23982f
- DOI
- 10.21203/rs.3.rs-2200813/v1
